<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149577">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01787188</url>
  </required_header>
  <id_info>
    <org_study_id>MEL3-12-02</org_study_id>
    <nct_id>NCT01787188</nct_id>
  </id_info>
  <brief_title>Study of Meloxicam Capsules to Treat Osteoarthritis Pain</brief_title>
  <official_title>A Phase 3, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy, and Safety Study of Meloxicam SoluMatrixâ„¢ Capsules in Patients With Pain Due to Osteoarthritis of the Knee or Hip</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iroko Pharmaceuticals, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iroko Pharmaceuticals, LLC</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Meloxicam [Test] Capsules are safe and
      effective for the treatment of osteoarthritis pain of the knee or hip.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The mean change from baseline in the WOMAC pain subscale score.</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">403</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Meloxicam Test Capsules low dose QD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Meloxicam Test Capsules low dose QD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meloxicam Test Capsules high dose QD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Meloxicam Test Capsules high dose QD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Capsule QD</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Capsule QD</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Meloxicam Test Capsules</intervention_name>
    <arm_group_label>Meloxicam Test Capsules low dose QD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Meloxicam Test Capsules</intervention_name>
    <arm_group_label>Meloxicam Test Capsules high dose QD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Capsules</intervention_name>
    <arm_group_label>Placebo Capsule QD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary diagnosis of Functional Class I-III OA of the hip or knee

          -  Chronic user of nonsteroidal anti-inflammatory drugs (NDAIDs) and/or acetaminophen
             for OA pain

          -  Discontinued all analgesic therapy at Screening

          -  For women of child-bearing potential: a woman who is not pregnant and not nursing,
             and who is practicing an acceptable method of birth control

        Exclusion Criteria:

          -  History of allergic reaction or clinically significant intolerance to acetaminophen,
             aspirin, or any NSAIDs, including meloxicam

          -  Requires continuous use of opioid or opioid combination products to control OA pain
             of the knee or hip

          -  Clinically significant unstable cardiac, respiratory, neurological, immunological,
             hematological, or renal disease

          -  Significant difficulties swallowing capsules or unable to tolerate oral medication

          -  Previous participation in another clinical study of Meloxicam Capsules or received
             any investigational drug or device or investigational therapy within 30 days before
             Screening
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles P Andrews, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diagnostics Research Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eddie Armas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Well Pharma Medical Research Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthew Barton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Office of Matthew Barton, MD</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Bouda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heartland Clinical Research, Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Champlin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beacon Clinical Research, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Melanie Christina, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Investigations of Texas, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James R Clark, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charlottesville Medical Research Center, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen Daniels, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Premier Research Group - Austin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard R Eckert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hypothetest, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brandon Essink, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meridian Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Flinchbaugh, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fleming Island Center for Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil Fraser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Troy Internal Medicine, PC / Research Department</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard M Glover, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heartland Research Associates, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John M Hill, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Avail Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Curtis S Horn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Quality Research Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffry Jacqmein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jacksonville Center for Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Montgomery, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Triad Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alan Kivitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Altoona Center for Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Kopp, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiant Research, Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregory F Lakin, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professional Research Network of Kansas, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sathish Modugu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Drug Trials America</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julie Mullen, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sterling Research Group, Ltd</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Nussdorfer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Research Associates, Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Naynesh Patel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wells Institute for Health Awareness</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kashyap Patel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peninsula Research, Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen J Poland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Community Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Larry D Reed, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Healthcare Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erich Schramm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Johns Center for Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Douglas R Schumacher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiant Research, Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Louis Stephens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Palmetto Clinical Trial Services, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Stich, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Westside Center for Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Haydn M Thomas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Trials Technology Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susann Varano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Consulting</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Larkin T Wadsworth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sundance Clinical Research, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert J Wagner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Community Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthew A Wenker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sterling Research Group, Ltd</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hayes T Williams, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Achieve Clinical Research, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Maynard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Community Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger Guthrie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arroyo Medical Group, Inc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Achieve Clinical Research, LLC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center</name>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <zip>95608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arroyo Medical Group, Inc</name>
      <address>
        <city>Pismo Beach</city>
        <state>California</state>
        <zip>93449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Consulting</name>
      <address>
        <city>Milford</city>
        <state>Connecticut</state>
        <zip>06460</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Avail Clinical Research</name>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fleming Island Center for Clinical Research</name>
      <address>
        <city>Fleming Island</city>
        <state>Florida</state>
        <zip>32003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westside Center for Clinical Research</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jacksonville Center for Clinical Research</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Well Pharma Medical Research Corporation</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Research, Inc</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <zip>32174</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Johns Center for Clinical Research</name>
      <address>
        <city>Ponte Vedra</city>
        <state>Florida</state>
        <zip>32081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Research Associates, LLC</name>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials Technology Inc</name>
      <address>
        <city>Prairie Village</city>
        <state>Kansas</state>
        <zip>66206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Professional Research Network of Kansas, LLC</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Research</name>
      <address>
        <city>Crestview Hills</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beacon Clinical Research, LLC</name>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <zip>02301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Research Associates, Inc</name>
      <address>
        <city>Traverse City</city>
        <state>Michigan</state>
        <zip>49684</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Troy Internal Medicine, PC / Research Department</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Healthcare Research</name>
      <address>
        <city>Hazelwood</city>
        <state>Missouri</state>
        <zip>63042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sundance Clinical Research, LLC</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Clinical Research, Inc</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridian Clinical Research</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Office of Matthew Barton, MD</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drug Trials America</name>
      <address>
        <city>Hartsdale</city>
        <state>New York</state>
        <zip>10530</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Triad Clinical Research</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27408</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sterling Research Group, Ltd</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sterling Research Group, Ltd</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Research - Anderson</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45255</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research, Inc</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wells Institute for Health Awareness</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altoona Center for Clinical Research</name>
      <address>
        <city>Duncansville</city>
        <state>Pennsylvania</state>
        <zip>16635</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research, Inc</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palmetto Clinical Trial Services, LLC</name>
      <address>
        <city>Clinton</city>
        <state>South Carolina</state>
        <zip>29325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Premier Research - Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Investigations of Texas, LLC</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Quality Research Inc</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnostics Research Group</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charlottesville Medical Research Center, LLC</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22911</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hypothetest, LLC</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 7, 2013</lastchanged_date>
  <firstreceived_date>February 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Meloxicam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
